Search

Your search keyword '"Schifone, Claudia"' showing total 5 results
Start Over Author "Schifone, Claudia"
5 results on '"Schifone, Claudia"'

2. Serological Response Following BNT162b2 Anti-Sars-Cov-2 mRNA Vaccination in Hematopoietic Stem Cell Transplantation Patients

Author

Attolico, Imma, primary, Tarantini, Francesco, additional, Carluccio, Paola, additional, Schifone, Claudia, additional, Delia, Mario, additional, Gagliardi, Vito Pier, additional, Perrone, Tommasina, additional, Gaudio, Francesco, additional, Longo, Chiara, additional, Giordano, Annamaria, additional, Sgherza, Nicola, additional, Curci, Paola, additional, Rizzi, Rita, additional, Ricco, Alessandra, additional, Russo Rossi, Antonella Vita, additional, Albano, Francesco, additional, Larocca, Angela Maria Vittoria, additional, Vimercati, Luigi, additional, Tafuri, Silvio, additional, and Musto, Pellegrino, additional

Published
2021
Full Text
View/download PDF

3. Serological response following BNT162b2 anti‐SARS‐CoV‐2 mRNA vaccination in haematopoietic stem cell transplantation patients.

Author

Attolico, Immacolata, Tarantini, Francesco, Carluccio, Paola, Schifone, Claudia Pia, Delia, Mario, Gagliardi, Vito Pier, Perrone, Tommasina, Gaudio, Francesco, Longo, Chiara, Giordano, Annamaria, Sgherza, Nicola, Curci, Paola, Rizzi, Rita, Ricco, Alessandra, Russo Rossi, Antonella, Albano, Francesco, Larocca, Angela Maria Vittoria, Vimercati, Luigi, Tafuri, Silvio, and Musto, Pellegrino

Subjects
HEMATOPOIETIC stem cell transplantation, MYELOFIBROSIS, SARS-CoV-2, CHRONIC leukemia, VACCINATION, COVID-19 vaccines
Abstract

In G1, all patients, allogeneic recipients and autologous recipients had significantly lower antibody levels than HC, whereas no differences were found in G2. Among the patients vaccinated >5 years after HSCT, allogeneic recipients had antibody titres comparable to HC; in contrast, autologous recipients had significantly lower titres than HC. Keywords: stem cell transplantation; severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccination; seroconversion EN stem cell transplantation severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccination seroconversion 928 931 4 02/14/22 20220215 NES 220215 Adult patients with haematological malignancies (HM) and coronavirus disease 2019 (COVID-19) have a higher mortality than healthy subjects.1-3 In particular, haematopoietic stem-cell transplantation (HSCT) recipients have a poor prognosis,4,5 strongly supporting the role of vaccination. Serological response following BNT162b2 anti-SARS-CoV-2 mRNA vaccination in haematopoietic stem cell transplantation patients. [Extracted from the article]

Published
2022
Full Text
View/download PDF

5. Mesangiogenic progenitor cells are forced toward the angiogenic fate, in multiple myeloma

Author

Pacini, Simone, primary, Montali, Marina, additional, Mazziotta, Francesco, additional, Schifone, Claudia P., additional, Macchia, Lucia, additional, Carnicelli, Vittoria, additional, Panvini, Francesca M., additional, Barachini, Serena, additional, Notarfranchi, Laura, additional, Previti, Giovanni Battista, additional, Buda, Gabriele, additional, and Petrini, Mario, additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results